The facility violated drug safety rules for five residents, including giving Xanax to one patient without informed consent and failing to monitor another for side effects from Norco, a narcotic painkiller containing hydrocodone.
Resident 84 received Norco tablets every four hours as needed for moderate to severe pain, but staff never documented monitoring for the drug's known side effects. The facility's own policy required watching for anorexia, confusion, lethargy, and severe constipation from opioid medications.
When inspectors interviewed RN 1 on January 9, the nurse confirmed there was no documentation showing side effect monitoring for the resident's Norco medication.
The same resident also received Xanax for anxiety without proper informed consent. The facility's policy required written consent signed by the resident or their representative before starting psychotropic medications. Resident 84 had been deemed capable of making medical decisions, but no consent form existed in the medical record.
RN 1 verified to inspectors that no informed consent had been obtained for the Xanax medication.
Additionally, the Xanax order violated federal rules limiting as-needed psychiatric medications to 14 days. Resident 84's prescription had continued beyond that timeframe without reassessment or documented justification.
The resident also received Remeron, an antidepressant, without evidence of non-drug interventions being tried first. Federal regulations require facilities to attempt non-pharmacological approaches before or alongside psychiatric medications unless contraindicated.
Resident 745 faced even more extensive medication violations. The patient received four different psychiatric drugs - quetiapine for auditory hallucinations, duloxetine for depression, divalproex sodium for mood swings, and Ativan for anxiety - without documentation of alternative treatments being attempted.
The resident had been deemed incompetent to make medical decisions, yet staff failed to monitor for side effects and behavioral changes from the Ativan use. The quetiapine was ordered as needed but hadn't been reassessed after more than 14 days, violating federal requirements.
Three other residents experienced similar violations with as-needed psychiatric medications extending beyond the 14-day limit without proper justification.
Resident 5 received lorazepam for anxiety starting November 21, 2024, but inspectors found no documented reason for extending the medication beyond 14 days. When LVN 4 was interviewed on January 10, the nurse stated she could not find any documentation justifying the extension.
Resident 19 received a similar lorazepam order on December 15, 2024, for 30 days - double the allowed timeframe for as-needed psychiatric medications. LVN 1 confirmed during inspection that no documented reason existed for the extended duration.
The facility's Director of Nursing acknowledged all findings when interviewed on January 10. The DON confirmed that as-needed psychiatric medication orders should be limited to 14 days and stated that any extension beyond that period required documented justification in the medical record.
Resident 64 presented a different type of consent violation. The patient signed informed consent forms for antidepressant, mood stabilizer, and other psychiatric medications despite being deemed incapable of making medical decisions. Federal rules require that only competent residents or their legal representatives can provide valid consent for psychiatric drug treatment.
Harbor Villa's own policies outlined the proper procedures that staff failed to follow. The facility's psychotropic drug policy, revised in March 2024, required non-pharmacological approaches to be used unless contraindicated, personal examination by the prescriber before prescribing, and written informed consent recorded in the medical record.
The policy also specified that PRN orders for psychotropic medications are limited to 14 days, with any extensions requiring documented rationale from the prescriber or attending physician.
A separate policy from July 2022 emphasized that psychiatric medications should not be prescribed on an as-needed basis unless necessary to treat a diagnosed specific condition documented in the clinical record.
The violations affected residents receiving treatment for various mental health conditions including depression, anxiety, mood disorders, and psychotic symptoms. Some patients were former firefighters dealing with trauma, while others experienced behavioral symptoms like yelling and agitation.
Federal inspectors classified the violations as having minimal harm or potential for actual harm to residents. However, the failures created risks of unnecessary medication use, ineffective treatment, and lack of proper monitoring that could negatively affect residents' mental, physical, and psychosocial wellbeing.
The inspection revealed systemic problems with the facility's medication management, particularly around psychiatric drugs that carry significant risks for elderly patients. These medications can cause falls, confusion, and other serious complications when not properly monitored or when given without appropriate safeguards.
Harbor Villa's failures spanned multiple aspects of safe medication practices - from obtaining proper consent to monitoring for adverse effects to following time limits designed to prevent unnecessary long-term use of potentially harmful drugs.
The facility must now develop and implement corrective measures to address these medication safety violations and ensure proper oversight of psychiatric and pain medications for all residents.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Harbor Villa Care Center from 2025-01-10 including all violations, facility responses, and corrective action plans.
